Table 1.
Baseline Living/Nonliving | Baseline Lexical Decision | Baseline Semantic Categorization | |||||||
---|---|---|---|---|---|---|---|---|---|
Trials 1–50 | Trials 51–100 | Trials 102–151 | Trials 1–50 | Trials 51–100 | Trials 102–151 | Trials 1–50 | Trials 51–100 | Trials 102–151 | |
Single Session Groups | |||||||||
PM-Hit Subgroup | 865 (133) | 895 (151) | 858 (141) | 657 (87) | 656 (91) | 677 (88) | 1129 (174) | 1136 (173) | 1113 (229) |
PM-Miss Subgroup | 887 (124) | 906 (161) | 906 (189) | 711 (112) | 705 (97) | 707 (118) | 1184 (203) | 1237 (213) | 1203 (200) |
Control Group | 874 (193) | 936 (202) | 901 (171) | 677 (100) | 694 (83) | 685 (71) | 1159 (175) | 1171 (208) | 1197 (207) |
Two Session Groups | |||||||||
PM-Hit Subgroup | 928 (167) | 1025 (215) | 1003 (153) | 652 (64) | 668 (63) | 681 (95) | 1103 (104) | 1139 (157) | 1115 (154) |
PM-Miss Subgroup | 870 (161) | 885 (153) | 857 (134) | 688 (124) | 676 (118) | 672 (113) | 1201 (233) | 1189 (236) | 1212 (258) |
Experimental Living/Nonliving | Experimental Lexical Decision | Experimental Semantic Categorization | |||||||
---|---|---|---|---|---|---|---|---|---|
Trials 1–50 | Trials 51–100 | Trials 102–151 | Trials 1–50 | Trials 51–100 | Trials 102–151 | Trials 1–50 | Trials 51–100 | Trials 102–151 | |
Single Session Groups | |||||||||
PM-Hit Subgroup | 790 (104) | 822 (146) | 884 (128) | 616 (68) | 648 (98) | 702 (98) | 1076 (183) | 1101 (162) | 1186 (182) |
PM-Miss Subgroup | 793 (143) | 832 (156) | 830 (180) | 666 (113) | 687 (109) | 689 (104) | 1125 (220) | 1149 (209) | 1141 (207) |
Control Group | 793 (157) | 822 (113) | 798 (109) | 616 (62) | 652 (78) | 646 (81) | 1062 (130) | 1127 (128) | 1113 (128) |
Two Session Groups | |||||||||
PM-Hit Subgroup | 883 (138) | 916 (111) | 1016 (153) | 650 (74) | 654 (68) | 723 (63) | 1061 (102) | 1115 (118) | 1203 (133) |
PM-Miss Subgroup | 797 (156) | 811 (144) | 790 (175) | 634 (96) | 668 (119) | 655 (114) | 1095 (207) | 1144 (203) | 1132 (203) |